Navigation Links
In Final Hour Prior to Litigation, Angel MedFlight's Air Ambulance Team Overturns Decision by Major Insurance Company
Date:8/31/2009

SCOTTSDALE, Ariz., Aug. 31 /PRNewswire/ -- Last year, Sally (a patient suffering from end stage liver failure) was in need of life flight transportation to be evaluated for a liver transplant. Her doctors told her she needed to receive the evaluation in order to get on the transplant list. Travel by ground ambulance or commercial flight were not an option due to her condition. Her health insurance company told her they would not cover the air ambulance medical transport. But last week, after four appeals and countless hours of work by Angel MedFlight's patient advocates, that decision was reversed. The insurance company will now pay the full amount of the air ambulance service provided by Angel MedFlight.

"When health insurance companies deny authorization every air ambulance company runs for the hills," said Jeremy Freer, Angel MedFlight CEO. "If they cannot get paid in advance, either from insurance or from the patient's family, they will not conduct the life flight. That's one of the big differences that sets Angel MedFlight apart from other air ambulance services. We will provide the care needed by the patient when no one else will."

Like many health insurance companies, Sally's insurer initially refused to approve the air ambulance service on the grounds that it was "not medically necessary." At that point, she was faced with two options: (1) giving up the chance of a transplant, or (2) taking the time to try and raise thousands of dollars for the life flight. "Sally may have had options but, sadly, she did not have extra time," Freer said. "That is when Angel MedFlight stepped in, reviewed her insurance policy and conducted the flight."

After conducting the life flight, Angel MedFlight's legal team, led by attorney Kelly LoCascio, Esq., went to bat for Sally. The claim was governed by the Employee Retirement Income Security Act of 1974 (ERISA), a federal law governing most health insurance policies that LoCascio says most patients and even many lawyers do not understand.

"Unfortunately, some health insurance companies frequently deny coverage for health benefits when they should be paid," LoCascio said. "They deny claims knowing patients will not understand the intricacies of ERISA law and often do not have the resources to hire a lawyer. Sometimes the patient is too involved with their health or just tired of the fight, and subsequently will miss crucial appeal deadlines. We take on the battle so our patients don't have to. In Sally's case, the system worked; Angel MedFlight performed the service, the insurer denied benefits, and after much exhaustive effort Angel MedFlight ensured that the insurance company carried out their obligations."

About Angel MedFlight Worldwide Air Ambulance Services:

Founded in 2006, Angel MedFlight is a full-service provider for medical ground and air ambulance transport. Part of Angel MedFlight's mission is to fulfill the urgent need for integrity and excellence in the air ambulance industry. Only the best aircraft, equipment and personnel are used. Angel MedFlight delivers on their promises, and goes to any lengths to make patient transport as smooth, comfortable and worry-free as possible.

    Contact Information:
    Mark Yost
    Business Development Manager
    myost(at)angelmedflight(dot)com
    877-264-3570
    www.angelmedflight.com


'/>"/>
SOURCE Angel MedFlight Worldwide Air Ambulance Services
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Nielsen Announces Final Entry Deadline Extension of September 10th for the First-Ever CLIO Healthcare Awards
2. Dont Miss Twinlabs(R) 2009 Mobile Beach Bash Grand Finale Celebration Labor Day Weekend
3. HBA Global Announces Finalists for the 2009 International Package Design Awards (IPDA)
4. Ranbaxy Receives Final Approval to Manufacture and Market Glycopyrrolate Tablets
5. Purple Communications Invites Greater San Ramon Community to Celebrate Ms. Ella Mae Lentz, Finalist in Dream Bigger Initiative
6. Par Pharmaceutical & Aveva Drug Delivery Systems Receive Final Approval to Market Generic Catapres TTS(R)
7. Covance and Merck & Co., Inc. Finalize Strategic Agreement
8. Mylan Pharmaceuticals Receives Final FDA Report and Reaffirms Its 48-Year Exemplary Record of Quality
9. Ranbaxy Receives Final Approval To Market Sumatriptan Succinate Tablets
10. AlloSource Chosen as Healthcare Finalist in 2009 Top Companies
11. Detroit Physician Among 10 Finalists for J.H. Kanter Prize
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... 19, 2017 , ... Sales Focus Inc. (SFI), a Maryland-based sales outsourcing company, ... Over the past 20 years SFI has been recognized as the world’s leader in ... clients into the US market. The new clients include: Panacea Pro, Campseekers, Contentmart, ...
(Date:1/19/2017)... ... 2017 , ... Each year, the Southeastern Society of Plastic ... of surgeons from over fifteen different countries come together to share and learn ... to breast reconstruction for breast cancer patients, teaching these surgical techniques which ...
(Date:1/18/2017)... ... January 18, 2017 , ... A recent video posting ... global discussion about the benefits of fidgeting to relieve stress and anxiety. No ... Their Think Ink Pen had just completed a successful Kickstarter campaign raising $67,000 ...
(Date:1/18/2017)... , ... January 18, 2017 , ... ... it from the number one doctor-recommended OTC antiperspirant, Certain Dri. , Excessive sweating ... untreated. , Certain Dri created this infographic to explain the seven types of ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... industry’s leading journal and most-read publication among specialty pharmacists and pharmacy professionals, ... through its Strategic Alliance Partnership (SAP) program, announced Brian Haug, president of ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... and PUNE, India , January 18, ... Allied Market Research, titled, "Breast Imaging Technologies Market by Type: ... global breast imaging technologies market size was valued at $2,544 ... by 2022, growing at a CAGR of 8.4% from 2016 ... Europe together accounted for over three-fourths market ...
(Date:1/18/2017)... 2017   Regenicin, Inc. (OTC Bulletin Board: ... the development and commercialization of regenerative cell therapies to ... reported the Company,s operating results for 2016 and an ... the Company described in its recent 10-K filing with ... accomplishments. The Company,s contract laboratory completed its evaluation of ...
(Date:1/18/2017)... DAVOS , Suiza, 18 de enero de 2017 ... biofarmacéuticas líderes lanzaron Access Accelerated, una iniciativa global para ... comunicables (NCD) y atención en países de renta baja ... NCD han alcanzado un punto de crisis, particularmente en ... casi el 80 por ciento de las muertes relacionadas ...
Breaking Medicine Technology: